Search

Search Constraints

You searched for: Author/Creator Yabe, Y.

Search Results

3. AB0377 Differences in Baseline Predictive Factors for Remission at 52 Weeks by Concomitant MTX Use during Tocilizumab Treatment Using Propensity Score Matched Groups. (15th July 2016)

5. AB0452 Efficacy of TOCILIZUMAB for Suppressing Radiographic Progression of Cervical Lesions in Patients with Rheumatoid Arthritis from Japanese Tbcr. (10th June 2014)

6. AB0466 The Outcome of Tocilizumab Treatment with Achievement of Glucocorticoids Withdrawal Against Rheumatoid Arthritis for 24 Months from TBC Registry. (9th June 2015)

9. AB0485 Predictive Factors for Achievement of Low Disease Activity or Remission at 52 Weeks in Switching from TNF Inhibitors to Abatacept with Background of low Dose or no Methotrexate: A Multicenter Observational Cohort Study in Japan. (9th June 2015)